GDF15 and hepatocellular carcinoma: In this study, we analyzed serum GDF15 levels in HCC patients prior to HAIC and found that higher GDF15 levels were associated with poorer treatment response, shorter OS and reduced progression-free survival (PFS), highlighting its potential as a prognostic biomarker for unresectable HCC undergoing HAIC.